FERRARI, GIULIANA
 Distribuzione geografica
Continente #
AS - Asia 2.780
EU - Europa 2.700
NA - Nord America 2.056
SA - Sud America 745
Continente sconosciuto - Info sul continente non disponibili 140
AF - Africa 64
OC - Oceania 5
Totale 8.490
Nazione #
US - Stati Uniti d'America 1.942
RU - Federazione Russa 1.590
CN - Cina 1.039
SG - Singapore 887
BR - Brasile 610
SE - Svezia 426
HK - Hong Kong 318
VN - Vietnam 255
IT - Italia 218
FR - Francia 129
DE - Germania 96
BD - Bangladesh 67
GB - Regno Unito 64
AR - Argentina 56
CA - Canada 55
IN - India 49
FI - Finlandia 33
PL - Polonia 33
JP - Giappone 31
MX - Messico 27
ID - Indonesia 26
AT - Austria 23
EC - Ecuador 21
IE - Irlanda 19
ZA - Sudafrica 19
ES - Italia 18
NL - Olanda 18
TR - Turchia 16
IQ - Iraq 14
VE - Venezuela 13
CL - Cile 11
CO - Colombia 11
UA - Ucraina 11
PK - Pakistan 10
MA - Marocco 9
PE - Perù 9
TN - Tunisia 9
PY - Paraguay 8
HN - Honduras 6
JM - Giamaica 6
KE - Kenya 6
KG - Kirghizistan 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
CH - Svizzera 5
MY - Malesia 5
PH - Filippine 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
IL - Israele 4
NP - Nepal 4
BH - Bahrain 3
JO - Giordania 3
KR - Corea 3
PA - Panama 3
QA - Qatar 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LB - Libano 2
LT - Lituania 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MT - Malta 1
NA - Namibia 1
NO - Norvegia 1
NR - Nauru 1
OM - Oman 1
RO - Romania 1
SC - Seychelles 1
Totale 8.345
Città #
Moscow 387
Singapore 364
Hong Kong 316
Ashburn 287
San Jose 243
Shanghai 197
Dallas 183
Beijing 159
Council Bluffs 139
Hefei 129
Lawrence 112
Princeton 112
Lauterbourg 111
Ho Chi Minh City 99
New York 71
Milan 69
Los Angeles 53
Hanoi 52
São Paulo 41
Santa Clara 35
Boardman 32
Warsaw 26
Helsinki 25
Tokyo 24
Phoenix 23
Rio de Janeiro 21
Brooklyn 20
Nuremberg 20
Dublin 19
Guangzhou 19
Orem 19
Poplar 16
Haiphong 15
Belo Horizonte 14
Munich 14
Rome 14
Vienna 14
Cesano Boscone 13
Johannesburg 13
Pune 13
Da Nang 12
Frankfurt am Main 12
London 12
Ankara 11
Chennai 11
Houston 11
Seattle 11
Montreal 10
Salvador 10
San Francisco 10
Shenzhen 10
Stockholm 10
The Dalles 10
Xi'an 10
Brasília 9
Dhaka 9
Omaha 9
Tianjin 9
Assago 8
Atlanta 8
Boston 8
Chicago 8
Denver 8
Manchester 8
Campinas 7
Hangzhou 7
Lima 7
Mexico City 7
Mumbai 7
Nova Iguaçu 7
Porto Alegre 7
Quito 7
Thái Bình 7
Toronto 7
Turin 7
Wuxi 7
Amsterdam 6
Bishkek 6
Brescia 6
Buffalo 6
Goiânia 6
New Delhi 6
Philadelphia 6
Reston 6
Tashkent 6
Tunis 6
Turku 6
Washington 6
Aracaju 5
Caracas 5
Caxias do Sul 5
Changsha 5
Charlotte 5
Guarulhos 5
Itajaí 5
Lahore 5
Miami 5
Santo André 5
Thái Nguyên 5
Anápolis 4
Totale 3.982
Nome #
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation 140
Long-term lineage commitment in haematopoietic stem cell gene therapy 138
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 126
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 117
A clinical protocol for transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA deficient SCID 116
Bone marrow as an alternative site for islet transplantation 113
A human PBL immunodeficient mouse model for in vivo preclinical studies of human gene therapy. 113
Correcting b-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity 112
NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice 111
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease 108
Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia 107
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells 106
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease 99
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets 99
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 95
A Highly conserved SOX6 double binding site mediates SOX6 gene downregulation in erythroid cells 94
Bone marrow as an alternative site for islet transplantation 94
Gene therapy using haematopoietic stem and progenitor cells 94
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy 93
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 91
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27 91
Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation 89
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers 89
Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer 86
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency 86
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 84
Characterization of Papilloma virus polypeptides from bovine cutaneous fibropapillomas 81
A non-producer interfering HIV-1 provirus can be transduced through a MLV-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus 81
Bone marrow-derived stem cells repopulate glomerular and tubular kidney components - Effect of hyperglycemia 80
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4 77
Clinical protocol: transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID 75
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 74
Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans 73
Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant 73
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 73
In vivo and in vitro models for the analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency. 72
Terapia genica e malattia ereditaria 72
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy 71
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 69
Stem cell plasticity: time for a reappraisal? 68
Muscle regeneration by bone marrow-derived myogenic progenitors 68
Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to Plerixafor alone 67
Safety of retroviral gene marking with a truncated NGF receptor 66
Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells 66
Retroviral vector gene-transfer into donor peripheral-blood lymphocytes for in-vitro selection and in-vivo immunomodulation of donor antitumor immunity after allo-BMT 65
Pancreatic islets recruit mesenchymal stem cells by release of chemokines 65
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice 65
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 65
The second transferrin receptor regulates red blood cell production in mice 64
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA- Immunodeficient Patients 64
Retroviral heterogeneity in mouse lymphomas 64
Clonal analysis of stably transduced human epidermal stem cells in culture 64
Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblasts 63
Selective engraftment of genetically modified hematopoietic stem cells by a truncated erythropoietin receptor 63
Protein kinase a-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity 63
Gene-transfer into peripheral-blood lymphocytes for in-vivo immunomodulation of donor antitumor immunity in a patient affected by EBV-induced lymphoma 63
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 62
Gene Therapy Approaches to Hemoglobinopathies 62
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells 61
Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia 61
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 60
Terapia Genica 60
Transfer of the ADA gene into human ADA-deficient T Lymphocytes reconstitutes specific immune functions 60
Hypomorhic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype 60
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia 60
Failure to correct murine muscular dystrophy 59
Strain polymorphism and tentative mapping of mouse ornithine decarboxylase 59
Conditioning Regimens in Long-Term Pre-Clinical Studies to Support Development of Ex Vivo Gene Therapy: Review of Nonproliferative and Proliferative Changes 59
Reversible Immortalization of Human Myogenic Cells by Site-Specific Excision of a Retrovirally Transferred Oncogene 58
TRANSFER OF THE HSV-TK GENE INTO DONOR PERIPHERAL-BLOOD LYMPHOCYTES FOR IN-VIVO IMMUNOMODULATION OF DONOR ANTITUMOR IMMUNITY AFTER ALLO-BMT 58
Gene therapy for beta thalassemia: preclinical studies on human cells 58
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity 57
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement 57
In vivo and in vitro models for analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency 57
Transcription Factor Binding Sites Are Genetic Determinant of Retroviral Integration in the Human Genome 57
Transcript imaging of human T helper cell development using oligonucleotide arrays 56
Transcription factor binding sites as genetic determinants of retroviral integration in the human genome 56
Towards the correction of the genetic defect in corneal keratinocytes from patients with macular corneal dystrophy type II 56
Retroviral vectors for human gene therapy 56
Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity 53
The GATA1-HS2 Enhancer allows persistent and position-independent expression of ß-globin transgene 53
Sox6 enhances erythroid differentiation in human erythroid progenitors 53
Mesenchymal Cells Appearing in Pancreatic Tissue Culture Are Bone Marrow-Derived Stem Cells With the Capacity to Improve Transplanted Islet Function 53
Preclinical Assessment of a Gene Therapy Approach to beta-Thalassemia 53
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia 53
gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants 53
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement 52
Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function 52
Persistent and Position Independent Transgene Expression in Erythroid Cells Transduced 52
Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression into muscle fibers in vivo 52
The influence of vector design on integration site selection by gamma-retroviral and lentiviral vectors 52
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies 51
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo 51
Deletion of a negatively acting sequence in a chimeric GATA-1 enchancer-LTR greatly increases retroviral-mediated erythroid expression 51
Vector design influences retroviral integration in human hematopoietic cells 51
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 51
Gene transfer into human primary myogenic cells. 51
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermiolysis bullosa 51
Retroviral vectors for human gene therapy 51
T-cell receptor genes in tassel-eared squirrels (Sciurus aberti). I. Genetic polymorhism and divergence in the Abert and Kaibab subspecies 50
Totale 7.203
Categoria #
all - tutte 60.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 0 0 43 0 2 1 51 4 5 1 5
2022/2023685 253 169 45 5 2 99 25 52 17 9 6 3
2023/2024369 10 20 30 104 15 45 11 5 0 7 19 103
2024/20251.663 218 42 16 62 48 142 295 177 261 171 105 126
2025/20265.213 409 378 351 804 405 134 424 368 1.411 284 121 124
2026/2027396 119 277 0 0 0 0 0 0 0 0 0 0
Totale 8.490